Form 4: Opus Genetics CFO Sells Shares
Insider Transaction (Form 4)
Robert E. Gagnon, Chief Financial Officer of Opus Genetics, Inc., sold 28,000 shares of common stock on September 3, 2026 for $4.54 per share.
Summary
- Open-market sale: disposed of 28,000 Common Stock at $4.54 ($127,212) on September 3, 2026; holds 556,375 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative signal: an insider sold $127,212 of stock on the open market.
Insider Transactions
Robert E. Gagnon — Officer (Chief Financial Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-03 | Open-market sale | Common Stock | 28,000 | $5 | $127.2K | 556,375 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-03 | Open-market sale (28,000 shares) |
Keywords
insider transaction, Form 4, IRD, Opus Genetics, Inc., bearish, Robert E. Gagnon
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.